---
schema_version: "secwatch.filing_event.v1"
accession: "0001387131-21-007425"
form_type: "8-K"
ticker: "TNXP"
cik: "0001430306"
company_name: "Tonix Pharmaceuticals Holding Corp."
filed_at: "2021-07-19T23:59:59+00:00"
generated_at: "2026-06-30T04:26:32.982455+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Tonix Pharmaceuticals appoints Carolyn E. Taylor to Board of Directors

## Summary
- Carolyn E. Taylor appointed to Board effective July 16, 2021, increasing board size to eight.
- Taylor brings 35+ years of corporate law experience, including partner at Covington & Burling.
- Granted 237,437 stock options vesting at 2022 annual meeting, exercisable at $0.98 per share.
- Will receive annual retainer of $50,000 for board service.

## SEC filing metadata
- accession: 0001387131-21-007425
- form_type: 8-K
- ticker: TNXP
- cik: 0001430306
- company_name: Tonix Pharmaceuticals Holding Corp.
- filed_at: 2021-07-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1430306/000138713121007425/0001387131-21-007425-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1430306/000138713121007425/tnxp-8k_071621.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001387131-21-007425
- JSON: https://secwatch.observer/filing/0001387131-21-007425.json
- Plain text: https://secwatch.observer/filing/0001387131-21-007425.txt

## Key facts
- Executive change
  Carolyn E. Taylor was appointed as director at Tonix Pharmaceuticals Holding Corp..
  - Action: appointed
  - Role: director
  source text: On July 16, 2021, the Directors (the “Board”) of Tonix Pharmaceuticals Holding Corp. (the “Company”), increased the size of the Board from seven to eight directors and, upon on the recommendation of its Nominating and Corporate Governance Committee, appointed Carolyn E. Taylor as director of the Company, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000138713121007425/0001387131-21-007425-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.